HHS will begin allocating Regeneron’s COVID-19 therapeutic this week

The treatment will be available at no cost to patients, although healthcare facilities may charge for the administration.
The treatment will be available at no cost to patients, although healthcare facilities may charge for the administration.

Read the full post on News Feed

MalloryHackett